Reversal of Atrial Mechanical Dysfunction After Cardioversion of Atrial Fibrillation: Implications for the Mechanisms of Tachycardia-Mediated Atrial Cardiomyopathy

Circulation

Volumn 108, Issue 16, 2003, Pages 1976-1984

  Sanders, Prashanthan ^b   Morton, Joseph B ^b   Kistler, Peter M ^b   Vohra, Jitendra K ^b   Kalman, Jonathan M ^b   Sparks, Paul B ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE

Author keywords

Arrhythmia; Atrium; Cardioversion; Echocardiography; Remodeling

Indexed keywords

AMIODARONE; ISOPRENALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; CARDIOMYOPATHY; CARDIOVERSION; CLINICAL ARTICLE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART ATRIUM PACING; HUMAN; MYOCARDIAL HIBERNATION; PRIORITY JOURNAL; SINUS RHYTHM; TACHYCARDIA; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CHRONIC DISEASE; CLINICAL TRIAL; DRUG EFFECT; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART ATRIUM; HEART PACING; HEART RATE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; STUNNED HEART MUSCLE; TIME; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; CHRONIC DISEASE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART ATRIA; HEART RATE; HUMANS; ISOPROTERENOL; MYOCARDIAL STUNNING; PROSPECTIVE STUDIES; TACHYCARDIA; TIME; TREATMENT OUTCOME;

EID: 0142023854     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000091408.45747.04     Document Type: Article

References (19)

1. Grimm RA, Stewart WJ, Maloney JD, et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol. 1993;22:1359-1366.
2. Grimm RA, Stewart WJ, Arheart K, et al. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events. J Am Coll Cardiol. 1997;29: 582-589.
3. Black IW, Fatkin D, Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: a multicenter study. Circulation. 1994;89:2509-2513.
4. Mulieri LA, Hasenfuss G, Leavitt B, et al. Altered myocardial force-frequency relation in human heart failure. Circulation. 1992;85:1743-1750.
5. Schotten U, Ausma J, Stellbrink C, et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation. 2001;103:691-698.
6. Sanders P, Morton JB, Morgan JG, et al. Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: implications for the mechanisms of tachycardia mediated atrial cardiomyopathy. Circulation. 2002;106:1806-1813.
7. Ausma J, Wijffels M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997;96:3157-3163.
8. Aime-Sempe C, Folliguet T, Rucker-Martin C, et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol. 1999;34:1577-1586.
9. Fatkin D, Kuchar DL, Thorburn CW, et al. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol. 1994;23:307-316.
10. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 1994;23:961-969.
11. 2+-ATPase in failing and nonfailing human myocardium. Circ Res. 1994;75:434-442.
12. Agmon Y, Khandheria BK, Meissner I, et al. Left atrial appendage flow velocities in subjects with normal left ventricular function. Am J Cardiol. 2000;86:769-773.
13. Kamalesh M, Copeland TB, Sawada S. Effect of inotropic stimulation on left atrial appendage function in atrial myopathy of chronic atrial fibrillation. Echocardiography. 2000;17:313-318.
14. Stefanadis C, Dernellis J, Stratos C, et al. Assessment of left atrial pressure-area relation in humans by means of retrograde left atrial catheterization and echocardiographic automatic boundary detection: effects of dobutamine. J Am Coll Cardiol. 1998;31:426-436.
15. Manning WJ, Silverman DI, Katz SE, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994;23:1535-1540.
16. Sun H, Gaspo R, Leblanc N, et al. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation. 1998;98:719-727.
17. Leistad E, Aksnes G, Verburg E, et al. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation. 1996;93:1747-1754.
18. Yue L, Feng J, Gaspo R, et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997;81:512-525.
19. Schotten U, Greiser M, Benke D, et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res. 2002;53:192-201.